Cleared Traditional

K202752 - AXS Vecta 46 Intermediate Catheter

K202752 is the FDA 510(k) clearance for AXS Vecta 46 Intermediate Catheter by Stryker Neurovascular. It is a Class 2 Neurology device (product code QJP) cleared through the Traditional 510(k) pathway after a 340-day FDA review.

K202752 · Stryker Neurovascular · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2021
Decision
340d
Days
Class 2
Risk

K202752 is an FDA 510(k) clearance for the AXS Vecta 46 Intermediate Catheter. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Stryker Neurovascular (Fremont, US). The FDA issued a Cleared decision on August 27, 2021 after a review of 340 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Stryker Neurovascular devices

Submission Details

510(k) Number K202752 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 2020
Decision Date August 27, 2021
Days to Decision 340 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
192d slower than avg
Panel avg: 148d · This submission: 340d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K202752.
Trevo Trak 21 Microcatheter
K211594 · Stryker Neurovascular · Nov 2021
Spartan MC 0165
K213451 · Spartan Micro · Nov 2021
TracStar LDP Large Distal Platform
K212224 · Imperative Care, Inc. · Sep 2021
Balloon Guiding Catheter
K202916 · Shanghai Heartcare Medical Technology Co., Ltd. · Aug 2021
SelectFlex Neurovascular Access System Family
K211893 · Q'Apel Medical, Inc. · Aug 2021
Route 92 Medical Full Length 088 Access System
K210635 · Route 92 Medical, Inc. · Jul 2021